Teva optimistic U.S. top court to rule in favour of MS drug patent
October 30, 2014 at 08:51 AM EDT
TEL AVIV, Oct 30 (Reuters) - Teva Pharmaceutical Industries is optimistic the U.S. Supreme Court will decide in its favour regarding patent protection for Copaxone, its multiple sclerosis treatment, Chief Executive Erez Vigodman said on Thursday.
